Mineralys Therapeutics, Inc. (MLYS) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 652.47M | 661.39M | 599.8M | 335.27M | 354.51M | 205.35M | 267.73M | 318M | 346.82M | 249.1M | 265.38M | 269.49M |
| Cash & Short-Term Investments | 646.06M | 656.63M | 217.6M | 324.92M | 343.03M | 198.19M | 263.6M | 311.12M | 338.56M | 236.57M | 253.76M | 261.1M |
| Cash Only | 112.78M | 172.92M | 217.6M | 101.79M | 165.01M | 114.09M | 97.27M | 67.86M | 90.42M | 49.3M | 86.3M | 101.14M |
| Short-Term Investments | 533.28M | 483.71M | 0 | 223.13M | 178.02M | 84.1M | 166.33M | 243.26M | 248.15M | 187.26M | 167.46M | 159.96M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.41M | 4.75M | 382.2M | 10.35M | 11.48M | 7.16M | 4.13M | 6.89M | 8.25M | 12.54M | 0 | 8.39M |
| Total Non-Current Assets | 392K | 420K | 151K | 455K | 435K | 552K | 521K | 491K | 430K | 2.53M | 12.18M | 21.73M |
| Property, Plant & Equipment | 32K | 38K | 7K | 22K | 38K | 53K | 69K | 42K | 51K | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.48M | 12.13M | 21.68M |
| Other Non-Current Assets | 360K | 382K | 144K | 433K | 397K | 499K | 452K | 449K | 379K | 51K | 51K | 51K |
| Total Assets | 652.86M | 661.81M | 599.95M | 335.72M | 354.94M | 205.9M | 268.25M | 318.49M | 347.25M | 251.64M | 277.56M | 291.22M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 83.94% | 221.42% | 123.65% | 5.41% | 2.22% | -18.17% | -3.35% | 9.37% | 13.32% | 119.88% | 126.67% | - |
| Total Current Liabilities | 14.72M | 15.11M | 23.52M | 22.17M | 13.39M | 14.65M | 31.32M | 28.4M | 19.2M | 10.48M | 13.54M | 6.21M |
| Accounts Payable | 1.12M | 2.02M | 1.12M | 3.16M | 373K | 479K | 3.11M | 1.71M | 4.26M | 601K | 5.57M | 2.2M |
| Days Payables Outstanding | 23.5K | - | 13.14K | - | - | - | - | - | 27.65K | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 11.29M | 7.56M | 18.52M | 2.62M | 1.15M | 3.58M | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 44.33x | 43.76x | 25.50x | 15.12x | 26.48x | 14.02x | 8.55x | 11.20x | 18.06x | 23.76x | 19.59x | 43.42x |
| Quick Ratio | 44.33x | 43.76x | 25.50x | 15.12x | 26.48x | 14.02x | 8.55x | 11.20x | 18.06x | 23.76x | 19.59x | 43.42x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 14.72M | 15.11M | 23.52M | 22.17M | 13.39M | 14.65M | 31.32M | 28.4M | 19.2M | 10.48M | 13.54M | 6.21M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -112.78M | -172.92M | -217.6M | -101.79M | -165.01M | -114.09M | -97.27M | -67.86M | -90.42M | -49.3M | -86.3M | -101.14M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 638.14M | 646.69M | 576.43M | 313.55M | 341.56M | 191.26M | 236.93M | 290.1M | 328.05M | 241.15M | 264.01M | 285.01M |
| Equity Growth % | 86.83% | 238.13% | 143.29% | 8.09% | 4.12% | -20.69% | -10.26% | 1.78% | 10.87% | 561.37% | 708.13% | - |
| Book Value per Share | 7.70 | 8.03 | 8.17 | 4.79 | 6.42 | 3.83 | 4.76 | 5.88 | 7.31 | 6.01 | 6.61 | 7.17 |
| Total Shareholders' Equity | 638.14M | 646.69M | 576.43M | 313.55M | 341.56M | 191.26M | 236.93M | 290.1M | 328.05M | 241.15M | 264.01M | 285.01M |
| Common Stock | 8K | 8K | 8K | 6K | 6K | 5K | 5K | 5K | 5K | 4K | 4K | 4K |
| Retained Earnings | -496.51M | -457.17M | -424.94M | -388M | -344.73M | -302.52M | -253.57M | -197.23M | -156.22M | -124.71M | -100.32M | -77.56M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -251.64M | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |